Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands

Description

This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.

Conditions

Cancer Colon

Study Overview

Study Details

Study overview

This is a prospective implementation study that will include patients that are identified as being average risk for colorectal cancer (CRC) according to USPSTF guidelines and who have opted to be screened for CRC. The purpose of this study is to understand implementation of a noninvasive screening test in primary care and internal medicine clinical settings, and the impact on patient acceptability and adherence of CRC screening.

Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice in the Outpatient Clinical Settings in the Appalachian Highlands

Blood-Based Colorectal Cancer (CRC) Screening Implementation Into Clinical Practice Highlands

Condition
Cancer Colon
Intervention / Treatment

-

Contacts and Locations

Johnson City

Johnson City Medical Center, Johnson City, Tennessee, United States, 37604

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    45 Years to 84 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    Ballad Health,

    Karen J. Elmore, MD, PRINCIPAL_INVESTIGATOR, Ballad Health

    Study Record Dates

    2024-10-31